Welcome to our dedicated page for P3 Health Partners news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 Health Partners stock.
P3 Health Partners Inc. (PIII) is a patient-centered, physician-led, and population health-focused healthcare company founded by Sherif Abdou and Amir Bacchus. The company is dedicated to transforming the way healthcare is delivered, with a mission to improve patient care, restore meaning to daily operations, and reinfuse care and health back into the healthcare system.
P3 operates with a unique model that aggregates and supports existing healthcare resources within the community to build an extensive network of providers. This network works collaboratively to deliver coordinated and integrated care to patients. The overarching goal is to improve patient outcomes, reduce healthcare costs, and enhance the overall experience for both patients and providers.
The team at P3 is composed of doctors, clinicians, and various support service professionals who share a deep passion for improving healthcare delivery. Recent achievements include significant growth in their provider network and successful partnerships that further their mission of delivering high-quality, cost-effective care.
Current projects at P3 include expanding their population health management services and implementing innovative care models that leverage data and technology to better serve their patient populations. Financially, P3 Health Partners Inc. continues to show robust performance, supported by its strong operational framework and strategic partnerships.
The company remains committed to its vision of transforming healthcare by working closely with physicians and healthcare providers to bring about meaningful changes in patient care delivery.
P3 Health Partners Inc. (NASDAQ: PIII) will have its CEO, Dr. Sherif Abdou, participate in the virtual panel named "Next Frontier – Value Based Care for Sub-Capitation/Specialties" at the Nephron 2nd Annual Physician Enablement Symposium on September 22 at 9:00 am EDT. P3 is a physician-led population health management company that supports over 2,500 primary care providers across five states, focusing on enhancing patient care and reducing costs through value-based care coordination.
P3 Health Partners Inc. (NASDAQ: PIII) has acquired the practice of Dr. Leonardo Serfino in Sierra Vista, Arizona. Dr. Serfino, an internal medicine specialist, will continue to care for his existing patients while accepting new Medicare Advantage patients. This acquisition expands P3 Arizona's network, which includes over 1,400 affiliated primary care providers in multiple counties. David Yarger, Arizona market president, emphasized that this partnership aligns with P3's focus on transforming healthcare to a value-based model that enhances patient outcomes and reduces costs.
P3 Health Partners Inc. (NASDAQ: PIII) announced the appointment of Allen Pate as president of P3 Health Partners-Nevada. Pate will oversee the P3 Nevada Medical Group, ensuring quality care for 20,000 Medicare Advantage patients in Clark and Nye Counties. His extensive healthcare management experience will aid in enhancing patient outcomes through a value-based care model. P3 remains dedicated to improving healthcare experiences while maintaining a network of over 400 primary care affiliate providers.
P3 Health Partners Inc. (NASDAQ: PIII) has expanded its operations in Nye County, Nevada, by acquiring Pahrump Cardiology & Family Practice (PCFP). This addition allows P3 to enhance healthcare access for patients in Pahrump, providing multi-specialty services on-site and eliminating the need for transport to Las Vegas. The acquisition adds approximately 375 patients to P3's platform, broadening its service reach across Nevada. PCFP boasts 12 providers and strengthens P3's network of over 400 primary care providers, supporting around 20,000 patients in the region.
P3 Health Partners Inc. (NASDAQ: PIII) invites investors to a fireside chat on August 31, 2022, at 2 pm ET. CEO Dr. Sherif Abdou and CMO Dr. Amir Bacchus will discuss the company's operations and value-based care model aimed at reducing healthcare delivery costs. The session will also highlight P3's achievements in 2022, emphasizing their commitment to improving patient outcomes through a network of over 2,500 primary care providers across five states.
P3 Health Partners Inc. (NASDAQ: PIII) has reached an agreement with Humana, allowing Humana Medicare Advantage members access to P3's primary care network in Clark and Nye Counties. From January 1, 2023, members will be able to visit P3's 10 clinics and over 400 PCPs. The initiative aims to enhance healthcare accessibility for Medicare beneficiaries in Southern Nevada. The announcement coincides with the Medicare Annual Election Period, beginning October 15, 2022, where members can select Humana plans pending regulatory approval.
P3 Health Partners Inc. (NASDAQ: PIII) announced an interview with its founder and CEO Dr. Sherif Abdou on the Benchtop Bios podcast. Dr. Abdou discusses P3's innovative value-based healthcare model aimed at enhancing patient care for Medicare Advantage patients. The podcast, featuring industry leaders, aims to inform biotech and healthcare investors about significant trends and discoveries shaping modern healthcare. P3, with over 2,500 affiliated primary care providers, focuses on improving patient outcomes and lowering costs through coordinated care.
P3 Health Partners Oregon has announced a multi-year partnership with Oregon State University Athletics, enhancing its visibility among senior fans. Starting in the 2022-23 season, P3 will introduce the first-ever Oregon State University Senior Cheer Squad. This initiative will include performances during women’s basketball games and coverage in digital programs. P3 will also sponsor game broadcasts, starting lineups for home basketball matches, and special events like Grandparents Day. This collaboration aims to strengthen community ties and engage senior patients who have connections with the university.
P3 Health Partners (NASDAQ: PIII) has been added to the Russell 3000 Index, effective June 27, 2022, marking a significant milestone for the company. This inclusion enhances visibility and liquidity for shareholders and confirms the company’s position among the top 4,000 U.S. stocks based on market capitalization. FTSE Russell, which manages the Russell indexes, oversees approximately $12 trillion in assets benchmarked against these indexes, further solidifying P3's market presence as it continues to work towards its strategic vision of transforming healthcare.
FAQ
What is the current stock price of P3 Health Partners (PIII)?
What is the market cap of P3 Health Partners (PIII)?
What is P3 Health Partners Inc.?
Who founded P3 Health Partners?
What is the main mission of P3 Health Partners?
How does P3 Health Partners operate?
What recent achievements has P3 Health Partners made?
What current projects is P3 Health Partners involved in?
How does P3 Health Partners aim to improve patient outcomes?
What makes P3 Health Partners unique?
How can I stay updated on P3 Health Partners' news?
What is the financial condition of P3 Health Partners?
